Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fukeyangrong capsules for infertility associated with diminished ovarian reserve
ChiCTR-IPC-15005870Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fukeyangrong capsules and estradiol valerate + dydrogesterone in Diminished Ovarian Reserve (DOR) and female infertility (3 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Estradiol, Follicle-stimulating hormone and 6 more. Planned start Feb 2015; status: not yet recruiting.
02
Drugs
Fukeyangrong capsulesestradiol valerate + dydrogesterone
03
Conditions
Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on ChiCTR-IPC-15005870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15005870.